Skip to content

Important Data on COVID-19 Profile in Africa

Important Data on COVID-19 Profile in Africa

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04847817
Acronym
AIDCO
Enrollment
574
Registered
2021-04-19
Start date
2020-08-01
Completion date
2022-03-01
Last updated
2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Africa, Coronavirus Infection

Keywords

Coronavirus infection, SARS-CoV, COVID-19, Transmission, Africa

Brief summary

The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.

Detailed description

In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study. Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.

Interventions

None listed

Sponsors

European and Developing Countries Clinical Trials Partnership (EDCTP)
CollaboratorOTHER_GOV
Leiden University Medical Center
CollaboratorOTHER
Institut de recherche en santé de surveillance épidémiologique et de formation
CollaboratorUNKNOWN
Université des Sciences de la Santé
CollaboratorUNKNOWN
Armauer Hansen Research Institute, Ethiopia
CollaboratorOTHER
Universität Tübingen
CollaboratorOTHER
Centre de Recherche Médicale de Lambaréné
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Molecular (PCR) confirmed COVID-19 patients hospitalized in referral centers, * Household contacts of hospitalized COVID-19 patient, * Provided signed informed consent.

Exclusion criteria

* Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
clinical and biological parameters of COVID-1914 daysInfection and disease progression - Pattern of virus transmission
SARS-CoV-2 transmissibility14 daysproportion of household contact who will become positive for SARS-COV2 using PCR

Countries

Gabon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026